| Exploring vitamin D metabolism and function in cancer SM Jeon, EA Shin Experimental & molecular medicine 50 (4), 1-14, 2018 | 631 | 2018 |
| A clinical drug library screen identifies clobetasol propionate as an NRF2 inhibitor with potential therapeutic efficacy in KEAP1 mutant lung cancer EJ Choi, BJ Jung, SH Lee, HS Yoo, EA Shin, HJ Ko, S Chang, SY Kim, ... Oncogene 36 (37), 5285-5295, 2017 | 104 | 2017 |
| Differential TM4SF5‐mediated SIRT1 modulation and metabolic signaling in nonalcoholic steatohepatitis progression J Ryu, E Kim, MK Kang, DG Song, EA Shin, H Lee, JW Jung, SH Nam, ... The Journal of Pathology 253 (1), 55-67, 2021 | 24 | 2021 |
| TM4SF5-dependent crosstalk between hepatocytes and macrophages to reprogram the inflammatory environment E Kim, H Um, J Park, JW Jung, JE Kim, H Lee, EA Shin, Y Pinanga, H Lee, ... Cell Reports 37 (7), 2021 | 17 | 2021 |
| TM4SF5-mediated liver malignancy involves NK cell exhaustion-like phenotypes H Sun, E Kim, J Ryu, H Lee, EA Shin, M Lee, H Lee, JH Lee, JH Yoon, ... Cellular and Molecular Life Sciences, 1-20, 2021 | 16 | 2021 |
| Crosstalk between TM4SF5 and GLUT8 regulates fructose metabolism in hepatic steatosis H Lee, E Kim, EA Shin, JC Shon, H Sun, JE Kim, JW Jung, H Lee, ... Molecular Metabolism 58, 101451, 2022 | 13 | 2022 |
| Liver‐originated small extracellular vesicles with TM4SF5 target brown adipose tissue for homeostatic glucose clearance JW Jung, JE Kim, E Kim, H Lee, H Lee, EA Shin, JW Lee Journal of Extracellular Vesicles 11 (9), e12262, 2022 | 12 | 2022 |
| Tetraspanin TM4SF5 in hepatocytes negatively modulates SLC27A transporters during acute fatty acid supply D Park, E Kim, H Lee, EA Shin, H Lee, JW Lee Archives of Biochemistry and Biophysics 710, 109004, 2021 | 8 | 2021 |
| Therapeutic effects of TM4SF5-targeting chimeric and humanized monoclonal antibodies in hepatocellular and colon cancer models D Ko, E Kim, EA Shin, SH Nam, J Yoon, JS Lee, Y Lee, S Park, K Ha, ... Molecular Therapy-Oncolytics 24, 452-466, 2022 | 4 | 2022 |
| Systemic TM4SF5 overexpression in ApcMin/+ mice promotes hepatic portal hypertension associated with fibrosis J Lee, E Kim, MK Kang, J Ryu, JE Kim, EA Shin, Y Pinanga, K Pyo, H Lee, ... BMB reports 55 (12), 609, 2022 | 3 | 2022 |
| Glucose‐mediated mitochondrial reprogramming by cholesterol export at TM4SF5‐enriched mitochondria‐lysosome contact sites JE Kim, SY Park, C Kwak, Y Lee, DG Song, JW Jung, H Lee, EA Shin, ... Cancer Communications 44 (1), 47-75, 2024 | 2 | 2024 |
| TM4SF5-mediated abnormal food-intake behavior and apelin expression facilitate non-alcoholic fatty liver disease features YD Pinanga, HA Lee, EA Shin, H Lee, K Pyo, JE Kim, EH Lee, W Kim, ... Iscience 26 (9), 2023 | 1 | 2023 |
| Association between hepatocyte TM4SF5 expression and gut microbiome dysbiosis during non-alcoholic fatty liver disease development YD Pinanga, K Pyo, EA Shin, H Lee, EH Lee, W Kim, S Kim, JE Kim, ... Life Sciences 358, 123164, 2024 | | 2024 |
| TM4SF5-targeting humanized antibody and use thereof SM Kim, JW Lee, D Ko, Y Junghwa, E Kim, SH Nam, EA SHIN US Patent 12,110,325, 2024 | | 2024 |
